• AAPL 167.04
  • TSLA 149.9
  • AMZN 179.17
  • MSFT 404.33
  • INTC 35.04
  • EURUSD 1.0646
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. ICCC.NASDAQ

ImmuCell Corporation (ICCC NASDAQ) stock market data APIs

$5.033 -0.02(-0.4%) as of April 18, 2024

ImmuCell Corporation Financial Data Overview

5.05
5.033
-
5.0611
5.033
4.26-6.05
39 142 K
7 751 K
17 472 K
-0.1471
0.596
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ICCC',
Type: 'Common Stock',
Name: 'ImmuCell Corporation',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BLQ5Q2',
ISIN: NULL,
CUSIP: NULL,
CIK: '811641',
EmployerIdNumber: '01-0382980',
FiscalYearEnd: 'December',
IPODate: '1987-04-30',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

ImmuCell Corporation Fundamental Data is available in our Financial Data APIs

  • Net Revenue 17 472 K
  • EBITDA -2 504 077
  • Earnings Per Share -0.75
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get ImmuCell Corporation Earnings via APIs

  • Latest Release 2024-02-28
  • EPS/Forecast NaN

Get ImmuCell Corporation End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get ImmuCell Corporation latest news via APIs

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023

PORTLAND, Maine, Nov. 13, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
  • EARNINGS RELEASES AND OPERATING RESULTS
  • IMMUCELL CORPORATION
  • NASDAQ:ICCC

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023

PORTLAND, Maine, Nov. 07, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
  • CALENDAR OF EVENTS
  • CONFERENCE CALLS/ WEBCASTS
  • IMMUCELL CORPORATION
  • NASDAQ:ICCC
Do you have any questions?
support@eodhistoricaldata.com